These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30333226)

  • 21. Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients.
    Zhang L; Mu Y; Zhang A; Xie J; Chen S; Xu F; Wang W; Zhang Y; Ren S; Zhou C
    Oncotarget; 2017 Jul; 8(28):45164-45177. PubMed ID: 28404886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects and mechanism on anti-leukemic activity of cytokine-induced killer cells with an endogenous expression of interleukin-21].
    Zhao N; Zhao MF; Rajbhandary S; Lu WY; Zhu HB; Ma L; You Q; Xiao X; Deng Q; Li YM
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(4):293-9. PubMed ID: 23578511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro influence of mycophenolate mofetil (MMF) and Ciclosporin A (CsA) on cytokine induced killer (CIK) cell immunotherapy.
    Bremm M; Huenecke S; Zimmermann O; Pfirrmann V; Quaiser A; Bonig H; Soerensen J; Klingebiel T; Rettinger E; Bader P; Cappel C
    J Transl Med; 2016 Sep; 14(1):264. PubMed ID: 27620209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical effect and safety of dendritic cell-cytokine-induced killer cell immunotherapy for pancreatic cancer: a systematic review and meta-analysis.
    Liu YL; Yang LX; Zhang F; Tang BS; Zhao LT; Zhu JR; Jin QY; Wang RX; Li YM
    Cytotherapy; 2019 Oct; 21(10):1064-1080. PubMed ID: 31462394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The proliferation, phenotype change and anti-tumor activity of cytokine induced killer cells].
    Cao JP; Jiang ZM; Zhang XC; Lin D; Chen W; Sun YH; Ma DC
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Sep; 21(5):583-6. PubMed ID: 16143062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic characterization and anti-tumor effects of cytokine-induced killer cells derived from cord blood.
    Zhang Z; Zhao X; Zhang T; Wang L; Yang L; Huang L; Li F; Liu J; Yue D; Wang F; Li J; Guan F; Xu Y; Zhang B; Zhang Y
    Cytotherapy; 2015 Jan; 17(1):86-97. PubMed ID: 25457278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the proliferation, cytotoxic activity and cytokine secretion function of cascade primed immune cells and cytokine-induced killer cells in vitro.
    Li GX; Zhao SS; Zhang XG; Wang WH; Liu J; Xue KW; Li XY; Guo YX; Wang LH
    Mol Med Rep; 2015 Aug; 12(2):2629-35. PubMed ID: 25955083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy with cytokine-induced killer cells in metastatic renal cell carcinoma.
    Su X; Zhang L; Jin L; Ye J; Guan Z; Chen R; Guo T
    Cancer Biother Radiopharm; 2010 Aug; 25(4):465-70. PubMed ID: 20701541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CIK cells from recurrent or refractory AML patients can be efficiently expanded in vitro and used for reduction of leukemic blasts in vivo.
    Wang Y; Bo J; Dai HR; Lu XC; Lv HY; Yang B; Wang T; Han WD
    Exp Hematol; 2013 Mar; 41(3):241-52.e3. PubMed ID: 23123634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resveratrol sensitized leukemia stem cell-like KG-1a cells to cytokine-induced killer cells-mediated cytolysis through NKG2D ligands and TRAIL receptors.
    Hu L; Cao D; Li Y; He Y; Guo K
    Cancer Biol Ther; 2012 May; 13(7):516-26. PubMed ID: 22406996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features.
    Gammaitoni L; Giraudo L; Leuci V; Todorovic M; Mesiano G; Picciotto F; Pisacane A; Zaccagna A; Volpe MG; Gallo S; Caravelli D; Giacone E; Venesio T; Balsamo A; Pignochino Y; Grignani G; Carnevale-Schianca F; Aglietta M; Sangiolo D
    Clin Cancer Res; 2013 Aug; 19(16):4347-58. PubMed ID: 23794732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic characterization and anticancer capacity of CD8+ cytokine-induced killer cells after antigen-induced expansion.
    Liu J; Wang L; Wang Y; Zhang W; Cao Y
    PLoS One; 2017; 12(4):e0175704. PubMed ID: 28426690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus.
    Pfirrmann V; Oelsner S; Rettinger E; Huenecke S; Bonig H; Merker M; Wels WS; Cinatl J; Schubert R; Klingebiel T; Bader P
    Cytotherapy; 2015 Aug; 17(8):1139-51. PubMed ID: 26072027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome.
    Ma L; Wang Y; Bo J; Han W; Wang Y; Zhang L; Wu X; Yu S; Liu R
    Clin Exp Immunol; 2016 Apr; 184(1):83-9. PubMed ID: 26660736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery.
    Li H; Wang C; Yu J; Cao S; Wei F; Zhang W; Han Y; Ren XB
    Cytotherapy; 2009; 11(8):1076-83. PubMed ID: 19929470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of humanized interleukin 21 on anti-leukemic activity of cytokine induced killer cells and the mechanism].
    Zhao N; Zhao MF; Rajbhandary S; Lu WY; Zhu HB; Xiao X; Deng Q; Li YM
    Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):823-8. PubMed ID: 23384903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice.
    Jung NC; Lee JH; Choi HJ; Hwang SU; Song JY; Seo HG; Choi J; Jung SY; Han SG; Lim DS
    Immunol Invest; 2016 Aug; 45(6):553-65. PubMed ID: 27410037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cord blood-derived and peripheral blood-derived cytokine-induced killer cells are sensitive to Fas-mediated apoptosis.
    Durrieu L; Dieng MM; Le Deist F; Haddad E
    Biol Blood Marrow Transplant; 2013 Sep; 19(9):1407-11. PubMed ID: 23856078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Short-term curative efficacy of autologous cytokine induced killer cells combined with low-dose IL-2 regimen containing immune enhancement by thymic peptide in elderly patients with B-cell chronic lymphocytic leukemia].
    Cai LL; Yang Y; Yang B; Zhu HL; Lu XC; Zhang WY; Yu RL; Chi XH; Wang Y; Dai HR; Han WD; Fan H; Li SX; Liu Y; Ran HH; Lin J; Tuo S; Tuo CW; Zhang F; Cao JP; Yao SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):564-70. PubMed ID: 22739156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and safety of chemotherapy combined with cytokine-induced killer cell /dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: A systematic review and meta-analysis.
    Mu Y; Zhou CH; Chen SF; Ding J; Zhang YX; Yang YP; Wang WH
    Cytotherapy; 2016 Sep; 18(9):1162-77. PubMed ID: 27421742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.